cardiovascular
diseas
cvd
continu
lead
caus
death
world
increas
inflamm
enhanc
thrombot
milieu
repres
two
major
complic
cvd
culmin
ischem
event
treatment
lifethreaten
complic
remain
reperfus
restor
blood
flow
howev
reperfus
strategi
may
result
ischemiareperfus
injuri
iri
secondari
variou
cardiovascular
patholog
includ
myocardi
infarct
stroke
further
inflammatori
thrombot
respons
deliv
inflammatori
mediat
affect
tissu
annexin
mimet
peptid
endogen
antiinflammatori
proresolv
mediat
known
signific
effect
resolv
inflamm
varieti
diseas
model
mount
evid
suggest
interact
formyl
peptid
receptor
fpr
famili
may
signific
role
mitig
iri
associ
complic
review
articl
focu
play
protect
role
ir
base
vascular
patholog
cardiovascular
diseas
cvd
main
caus
morbid
mortal
worldwid
sole
respons
death
million
peopl
vast
major
due
either
ischem
heart
diseas
ihd
cerebrovascular
diseas
led
exponenti
increas
healthcar
cost
estim
increas
total
medic
care
cost
unit
state
us
alon
rise
billion
billion
year
addit
burden
cvd
increas
tremend
develop
countri
predict
overtak
infecti
diseas
lead
caus
mortal
year
mani
acut
cardiovascular
event
acut
ischem
stroke
ai
myocardi
infarct
mi
due
eg
unhealthi
vascular
state
result
prolong
atherosclerosi
coronari
arteri
diseas
diabet
uncontrol
hypertens
age
addit
studi
suggest
behavior
psychosoci
includ
bereav
environment
factor
also
trigger
contribut
acut
cardiovascular
event
ai
mi
lifethreaten
condit
requir
prompt
treatment
consist
rapid
restor
blood
flow
follow
subsequ
manag
consist
antiinflammatori
strategi
neuroand
cardioprotect
secondari
prevent
howev
restor
blood
suppli
reoxygen
paradox
lead
exagger
tissu
injuri
tissu
destruct
term
ischemiareperfus
injuri
iri
restor
homeostasi
essenti
mechan
activ
cell
accumul
site
ischemia
reperfus
multipl
studi
shown
enhanc
gener
oxid
result
activ
deposit
complement
phospholipas
pla
mediat
product
ltb
platelet
activ
factor
paf
furthermor
abund
evid
suggest
role
platelet
iri
mediat
microvascular
thrombosi
well
ensu
inflamm
plateletplatelet
well
plateletleukocyt
interact
commun
lead
releas
broad
rang
proinflammatori
molecul
includ
highmobl
group
box
protein
cell
differenti
ligand
polyp
alphabeta
further
thromboinflammatori
environ
contribut
innat
adapt
immun
respons
annexin
member
superfamili
thirteen
annexin
protein
compris
amino
acid
least
twelv
distinct
ca
phospholipid
bind
protein
member
superfamili
aptli
name
due
capabl
annex
phospholipid
membran
protein
discov
abil
inhibit
pla
activ
eicosanoid
synthesi
antiinflammatori
action
seen
guinea
pig
lung
model
glucocorticoid
gc
treat
rat
model
rat
medulla
cell
experi
uniqu
ntermin
region
activ
biolog
portion
embed
within
core
expos
elev
ca
level
mm
ntermin
region
member
annexin
superfamili
believ
fingerprint
endow
biolog
activ
howev
region
interest
core
protein
known
also
possess
antiinflammatori
properti
instanc
abundantli
present
cell
myeloid
origin
neutrophil
monocyt
macrophag
rest
condit
present
within
cytoplasm
extrud
upon
cell
activ
molecular
mechan
respons
secret
vari
cell
cell
eg
neutrophil
resid
gelatinas
granul
releas
upon
neutrophil
activ
eg
neutrophilendotheli
interact
attach
outer
leaflet
plasma
membran
undergo
conform
chang
expos
ntermin
region
case
macrophag
releas
via
atpbind
cassett
abc
transport
system
regul
gc
gc
increas
gene
also
secret
exist
intracellular
pool
stimul
protein
kinas
c
pkc
activ
antiinflammatori
proresolv
effect
kda
protein
mediat
shed
lselectin
result
decreas
neutrophil
adhes
endothelium
restrict
transmigr
pharmacolog
intervent
shown
decreas
neutrophil
roll
adhes
endothelium
increas
detach
adher
induc
neutrophil
apoptosi
perretti
flower
demonstr
attenu
induc
neutrophil
migrat
murin
air
pouch
addit
get
et
al
show
endogen
exogen
abl
inhibit
neutrophil
monocyt
recruit
murin
periton
caviti
find
suggest
retain
antiinflammatori
action
irrespect
stimuli
furthermor
may
undergo
chang
cleavag
induc
neutrophil
specif
proteas
eg
cathepsin
g
cg
neutrophil
elastas
ne
although
unknown
whether
cleavag
process
occur
inactiv
produc
homeostasi
produc
bioactiv
fragment
act
prodrug
mimet
peptid
ntermin
deriv
bind
formyl
peptid
receptor
fpr
famili
seven
transmembran
gproteincoupl
receptor
gpcr
variou
cell
type
express
fpr
especi
myeloid
cell
eg
neutrophil
monocyt
three
fpr
member
exist
human
term
also
known
lxa
receptor
share
amino
acid
sequenc
homolog
share
amino
acid
homolog
mice
fpr
famili
complex
consist
least
eight
member
mous
share
sequenc
homolog
human
homolog
fpr
primarili
coupl
g
protein
g
g
upon
bind
ligand
formylmetleuph
fmlp
g
protein
activ
trigger
releas
sever
second
messeng
ca
intracellular
store
activ
phospholipas
c
plc
pld
pla
neutrophil
predominantli
sens
inflammatori
stimuli
via
fpr
perform
proa
well
antiinflammatori
function
depend
upon
pathophysiolog
statu
ligand
bind
inflammatori
state
neutrophil
fpr
particip
variou
biolog
function
includ
chemotaxi
degranul
ro
product
promot
neutrophilplatelet
interact
enabl
apoptosi
phagocytosi
abil
fpr
perform
wide
rang
biolog
function
due
abil
interact
multitud
agonist
antagonist
rang
formyl
nonformyl
proteinspeptid
small
molecular
weight
compound
eg
fmlp
hisphetyrleupromet
hfylpm
chemoattract
monocyt
neutrophil
hiv
envelop
protein
detail
descript
fpr
ligand
biolog
function
given
tabl
among
fpr
member
versatil
interact
multitud
ligand
result
antiinflammatori
proresolv
lxa
well
proinflammatori
serum
amyloid
saa
cathelicidin
function
tabl
divers
effect
also
seem
partli
due
abil
facilit
bias
agon
enabl
differ
dimer
state
ligand
bind
bind
saa
andor
cathelicidinassoci
antimicrobi
peptid
result
neutrophil
activ
cytokin
releas
increas
neutrophil
infiltr
lifespan
howev
bind
antineuron
nuclear
antibodi
inhibit
neutrophil
infiltr
promot
neutrophil
apoptosi
push
macrophag
toward
less
proinflammatori
phenotyp
increas
rate
phagocytosi
macrophag
ongo
studi
show
signal
associ
neutrophil
oxid
burst
induc
rapid
revers
increas
mitochondri
membran
potenti
within
neutrophil
addit
mitochondrialderiv
ligand
also
function
chemotact
damageassoci
molecular
pattern
molecul
damp
also
known
alarmin
danger
signal
activ
innat
immun
system
function
less
well
character
although
express
eosinophil
monocyt
macrophag
dendrit
cell
evid
suggest
play
role
allerg
reaction
dendrit
cell
matur
cerebrovascular
diseas
second
common
caus
death
ihd
third
lead
caus
disabilityadjust
lifeyear
dali
account
eight
million
death
worldwid
ai
common
manifest
cerebrovascular
diseas
limit
therapeut
option
date
mainli
due
complex
pathophysiolog
ai
evolv
local
due
underli
atherogenesi
vasculopathi
thrombot
occlus
distant
embolu
aris
heart
embol
occlus
event
result
activ
ischem
cascad
culmin
sudden
tissu
hypoxia
cellular
dysfunct
cell
death
subsequ
disrupt
bloodbrain
barrier
main
goal
ai
manag
rapid
recan
occlud
vessel
restor
blood
suppli
limit
focal
ischem
insult
global
hypox
injuri
howev
variou
anim
model
demonstr
reperfus
actual
result
tissu
injuri
molecular
cellular
level
translat
recurr
stroke
seen
mani
patient
sever
strategi
current
develop
gener
neuroprotect
agent
prevent
iri
irrevers
brain
injuri
ai
iri
play
signific
detriment
role
ai
result
widespread
inflamm
due
immun
respons
ischemia
result
complex
accumul
variou
cellular
mediat
includ
activ
leukocyt
neutrophil
monocyt
lymphocyt
activ
platelet
alongsid
activ
resid
cell
eg
microglia
astrocyt
superoxid
gener
cytokin
tumor
necrosi
beta
product
hypoxia
defici
vasodil
particular
endotheli
nitric
oxid
shown
enlarg
stroke
size
tlr
also
shown
play
signific
role
cerebr
iri
especi
mediat
respons
microgli
cell
tlr
demonstr
upregul
express
cellular
adhes
molecul
cam
selectin
facilit
neuron
injuri
activ
microglia
macrophag
increas
express
eg
p
eselectin
enhanc
leukocyt
roll
stick
vessel
surfac
addit
crosstalk
thrombosi
inflamm
cerebr
ischemia
result
thromboinflammatori
state
subsequ
restor
blood
flow
result
cellular
molecular
respons
involv
innat
well
adapt
arm
immun
activ
complement
system
coagul
system
respons
lead
damag
affect
tissu
addit
injuri
caus
product
ro
involv
inflammatori
cell
dendrit
cell
neutrophil
play
huge
role
first
immun
cell
infiltr
ischem
region
brain
accumul
within
six
hour
reperfus
increas
tissu
infarct
size
six
twentyfour
hour
time
maxim
infarct
relat
close
time
cours
neutrophil
infiltr
reperfus
addit
interact
cell
eg
endotheli
cell
platelet
neutrophil
also
produc
mani
prothrombot
mediat
neutrophil
extracellular
trap
net
serin
proteas
eg
cg
ne
promot
thrombu
format
furthermor
matrix
surfac
integrin
receptor
ag
express
neutrophil
play
signific
role
compromis
bloodbrain
barrier
bbb
acceler
thrombu
format
bind
fibrinogen
von
willebrand
factor
vwf
glycoprotein
ib
gpib
respect
role
annexin
ai
shown
act
variou
way
mitig
cerebr
iri
work
shown
signific
effect
peptid
mimet
diminish
leukocyt
adhes
traffick
mainli
act
autocrineparacrin
fashion
decreas
leukocyteendotheli
interact
inhibit
releas
proinflammatori
prothrombot
cytokin
regul
neutrophilplatelet
interact
human
recombin
peptid
mimet
shown
markedli
reduc
lesion
size
clinic
score
marker
leukocyt
infiltr
murin
middl
cerebr
arteri
occlus
mcao
model
recent
show
exogen
administr
ntermin
peptid
attenu
neutrophil
platelet
activ
neutrophilplatelet
aggreg
murin
cerebr
microvasculatur
induct
cerebr
iri
mice
also
shown
protect
rat
demonstr
intracerebroventricular
administr
peptid
reduc
infarct
size
cerebr
edema
two
hour
post
cerebr
ischemia
mcarthur
et
al
demonstr
anim
lack
receptor
ie
knockout
mice
show
markedli
greater
bbb
leakag
postischemia
wildtyp
wt
counterpart
addit
play
role
mediat
permeabl
bbb
cristant
et
al
show
knockout
mice
possess
disorgan
actin
cytoskeleton
due
increas
activ
rhoa
small
gtpase
disrupt
occludin
vecadherin
furthermor
blood
cell
express
also
brain
resid
cell
microglia
potenti
target
antiinflammatori
proresolv
effect
parent
compound
ihd
lead
caus
mortal
estim
million
death
worldwid
despit
signific
improv
year
surviv
rate
due
advanc
reperfus
therapi
secondari
heart
failur
due
ensu
inflamm
major
caus
diseas
burden
myocardi
infarct
overproduct
ro
cardiac
tissu
remodel
ensu
proinflammatori
immun
respons
main
caus
miri
pharmacolog
administr
antioxid
calcium
channel
blocker
shown
promis
result
experiment
set
howev
intervent
fail
achiev
success
clinic
studi
mi
last
twenti
minut
cardiomyocyt
death
initi
subendocardium
expand
toward
epicardium
deplet
atp
ischemia
due
halt
oxid
phosphoryl
inhibit
myocardi
contractil
function
ischemia
lead
ca
overload
caus
damag
ultrastructur
myocardi
initi
thought
reperfus
limit
infarct
size
preserv
left
ventricular
lv
systol
function
howev
grow
scientif
evid
proven
reperfus
induc
cardiomyocyt
death
reperfus
ihd
result
massiv
outpour
ischem
tissu
activ
leukocyt
especi
neutrophil
mediat
eg
complement
fragment
ro
proinflammatori
cytokin
promot
injuri
cardiomyocyt
death
sever
intervent
shown
reduc
infarct
size
experiment
mir
condit
intervent
includ
administr
biolog
inhibit
pselectin
pharmacolog
inhibit
complement
activ
leukocyt
deplet
neutrophil
play
central
role
miri
first
cell
summon
result
acceler
proinflammatori
respons
includ
product
inflammatori
mediat
eg
cg
ne
ro
lead
microvascular
injuri
cardiomyocyt
death
extracellular
matrix
ecm
degrad
remodel
neutrophil
activ
iri
promot
express
adhes
molecul
lead
adher
neutrophil
endothelium
follow
transmigr
direct
interact
cardiac
myocyt
involv
ihd
ntermin
peptid
shown
cardioprotect
variou
iri
model
damico
et
al
demonstr
decreas
infarct
size
upon
infus
recombin
protect
effect
confirm
la
et
al
evidenc
administr
ntermin
peptid
decreas
infarct
size
reduc
mpo
content
infarct
heart
treatment
also
attenu
loss
fiber
organ
decreas
mpo
activ
reduc
macrophag
inflammatori
protein
level
leukocyt
extravag
cardiac
tissu
peptid
shown
preserv
cardiomyocyt
contractil
function
reduc
cardiac
myocyt
injuri
protect
least
part
associ
activ
pkc
k
atp
channel
addit
qin
et
al
demonstr
exogen
administr
onset
reperfus
increas
cardiomyocyt
viabil
recoveri
lv
function
associ
signal
hematopoiet
progenitor
stem
cell
hpsc
mobil
differenti
shown
regul
eg
defici
result
increas
cardiac
necrosi
inflamm
hypertrophi
fibrosi
result
exagger
cardiac
infarct
size
eight
day
myocardi
infarct
effect
link
greater
expans
alter
mobil
hpsc
increas
circul
neutrophil
platelet
alter
macrophag
inflammatori
phenotyp
function
recent
larg
focu
pharmacolog
concept
biasedagon
multipl
activ
conform
receptor
exist
elicit
distinct
signal
yield
multipl
function
outcom
smallmolecul
agonist
compound
shown
bias
agon
enabl
fpr
base
proresolv
biolog
without
chang
calcium
mobil
henc
provid
superior
cardioprotect
similar
attenu
earli
late
inflammatori
respons
reperfus
mi
kinas
seem
play
signific
role
kidney
transplant
lead
caus
kidney
iri
end
approxim
peopl
wait
kidney
transplant
due
greater
avail
vast
major
kidney
transplant
take
place
use
organ
cadaver
donor
instanc
kidney
transplant
took
place
organ
came
cadaver
donor
came
live
donor
howev
cadaver
donor
kidney
suscept
iri
due
prolong
ischemia
cold
condit
case
live
donor
although
ischem
period
shorter
organ
still
subject
warm
ischemia
harvest
may
also
result
iri
final
sever
injuri
occur
reperfus
phase
recipi
due
activ
innat
adapt
immun
respons
inde
mani
renal
transplant
recipi
immunosuppress
therapi
prevent
graft
dysfunct
figur
show
kidney
transplant
fail
within
month
transplant
within
year
within
three
year
furthermor
year
total
kidney
transplant
retranspl
due
failur
transplant
kidney
therefor
urgent
unmet
clinic
need
find
better
therapi
prevent
graft
reject
renal
iri
character
decreas
glomerular
filtrat
rate
gfr
volum
fluid
filter
kidney
minut
ischemia
lead
deplet
atp
turn
inhibit
activ
tubular
na
k
atpas
redistribut
na
h
exchang
condit
caus
decreas
reabsorpt
na
tubular
cell
due
increas
na
filtrat
gfr
limit
via
tubuloglomerular
feedback
mechan
avoid
na
water
loss
addit
ro
product
increas
iri
caus
renal
tubul
injuri
via
oxid
protein
lipid
membran
dna
damag
therebi
trigger
apoptosi
tubular
epitheli
cell
shed
tubular
lumen
caus
tubular
obstruct
paracellular
diffus
water
ion
macromolecul
becom
unregul
upon
loss
tubular
cell
increas
backleak
interstitium
blood
vessel
also
decreas
gfr
thu
said
gfr
also
decreas
synerget
effect
cell
surfac
area
tubular
obstruct
addit
apoptosi
lead
decreas
cellcel
interact
increas
vascular
permeabl
deplet
atp
also
inhibit
activ
ca
atpas
caus
increas
intracellular
calcium
level
induc
cytoskelet
damag
increas
vascular
permeabl
inflamm
play
major
role
renal
iri
due
enhanc
product
proinflammatori
cytokin
eg
shown
work
mainli
jakstat
signal
pathway
inhibit
jakstat
signal
pathway
shown
improv
kidney
iri
outcom
cytokin
eg
releas
upon
renal
tubular
cell
activ
damag
due
iri
iri
renal
iri
neutrophil
first
cell
respond
injuri
site
result
product
multipl
mediat
includ
ne
tissu
type
plasminogen
activ
hepatocyt
growth
factor
express
neutrophil
also
caus
renal
microvasculatur
obstruct
bind
endotheli
cell
platelet
addit
adhes
molecul
eg
pselectin
major
regul
neutrophil
recruit
shown
involv
kidney
iri
recent
kelli
et
al
show
kidney
mice
display
protect
iri
confirm
block
specif
antibodi
takada
et
al
show
solubl
pselectin
ligand
decreas
neutrophil
transmigr
rat
ischem
kidney
role
kidney
iri
nascent
stage
howev
studi
shown
may
exert
protect
role
eg
rat
model
renal
iri
exogen
administr
peptid
reduc
tubular
necrosi
b
influx
phagocyt
cell
neutrophil
monocyt
c
sodium
potassium
excret
gfr
therebi
improv
function
recoveri
outcom
cyclosporin
immunosuppress
use
avoid
organ
transplant
reject
major
side
effect
cyclosporin
treatment
nephrotox
compound
decreas
renal
blood
flow
increas
renal
vascular
resist
common
condit
renal
iri
howev
exogen
administr
shown
revers
side
effect
diabet
metabol
syndrom
affect
mani
organ
includ
kidney
diabet
patient
develop
nephropathi
shown
afford
protect
murin
diabet
nephropathi
decreas
erk
jnk
activ
akt
signal
suggest
could
potenti
therapeut
strategi
treat
renal
dysfunct
caus
diseas
diabet
iri
gi
system
mainli
seen
abdomin
thorac
vascular
surgeri
also
associ
small
bowel
transplant
hemorrhag
shock
gi
complic
lead
mesenter
ischemia
iri
mortal
rate
associ
mesenter
iri
rang
enterocyt
main
intestin
cell
resist
short
term
hypoxia
howev
prolong
hypoxia
caus
irrevers
cell
death
result
product
variou
damp
eg
nucleic
acid
heat
shock
protein
ischemia
caus
inactiv
enzym
cytochrom
oxidas
superoxid
dismutas
upon
reoxygen
oxid
phosphoryl
occur
result
ro
product
trigger
apoptosi
enterocyt
caus
intestin
barrier
disrupt
also
increas
intracellular
calcium
concentr
lead
chang
cytoskeleton
damag
cellcel
junction
therebi
increas
vascular
permeabl
system
inflamm
signific
compon
intestin
iri
loss
barrier
function
facilit
movement
microbiota
product
gut
blood
stream
molecular
pattern
associ
microb
product
known
pathogenassoci
molecul
pattern
pamp
pamp
damp
bind
tlr
immun
cell
activ
local
inflammatori
respons
product
cytokin
cell
adhes
molecul
chemokin
receptor
via
induct
step
lead
recruit
infiltr
leukocyt
caus
tissu
damag
inflam
intestin
mucosa
also
produc
whole
plethora
differ
inflammatori
cytokin
chemokin
eg
significantli
increas
leukocyt
infiltr
exacerb
inflamm
diseas
protect
role
giassoci
iri
shown
play
protect
role
gastrointestin
iri
shown
intraven
administr
inhibit
leukocyt
adhes
emigr
mous
mesenter
iri
model
induc
clamp
superior
mesenter
arteri
follow
reperfus
loss
epitheli
cell
barrier
major
characterist
intestin
iri
effect
peptid
epitheli
cell
barrier
studi
intestin
iri
model
afford
protect
gastrointestin
inflammatori
murin
model
includ
coliti
gastric
ulcer
leoni
et
al
demonstr
deliv
local
intestin
use
polymer
nanoparticl
enhanc
epitheli
cell
restor
coliti
martin
et
al
show
posit
effect
peptid
enhanc
heal
process
gastric
mucos
damag
reduc
ulcer
area
furthermor
group
also
demonstr
hemorrhag
lesion
greater
mice
upon
induct
gastric
ulcer
leoni
et
al
suggest
exhibit
posit
role
intestin
wound
heal
upon
bind
activ
src
downstream
ro
produc
caus
rapid
revers
oxid
subsequ
inactiv
phosphatas
pten
ptppest
inactiv
phosphatas
lead
activ
focal
adhes
protein
involv
cell
movement
fax
paxillin
therebi
increas
intestin
epitheli
cell
movement
wound
repair
intestin
iri
also
major
caus
acut
lung
injuri
ali
treatment
exogen
shown
reduc
pulmonari
vascular
leakag
decreas
neutrophil
infiltr
mpo
content
lung
tissu
follow
intestin
iri
possibl
induc
releas
antiinflammatori
cytokin
decreas
releas
proinflammatori
cytokin
babbin
et
al
also
show
dextransulf
sodium
dss
induc
coliti
model
abl
regul
intestin
mucos
injuri
inflamm
via
engag
addit
defici
mice
fail
regain
weight
show
improv
diseas
activ
index
mucos
injuri
upon
withdraw
diseas
dssinduc
coliti
model
advoc
crucial
benefici
role
decreas
neutrophilendothelium
interact
flow
chamber
regul
leukocyteplatelet
respons
cerebr
microvasculatur
decreas
pulmonari
arteri
pressur
decreas
inflammatori
cytokin
product
decreas
lung
tissu
damag
follow
ir
decreas
infarct
size
post
myocardi
ir
reduc
myeloperoxidas
activ
prevent
endotoxin
induc
inotrop
cyclooxygenas
gene
express
decreas
adhes
transmigr
inflammatori
mesenteri
vivo
ai
ir
induc
lung
injuri
mi
mesenter
ischemia
activ
neutrophil
nadph
oxidas
inflamm
annexin
cyclosporin
h
decreas
neutrophil
activ
inflamm
dca
inhibit
fmlpinduc
monocyt
neutrophil
chemotaxi
calcium
mobil
inflamm
ebola
peptid
inhibit
fmlp
interact
cho
cell
viral
pathogenesi
flipr
inhibitori
protein
flipr
exert
antiinflammatori
activ
inhibit
calcium
mobil
cell
migrat
toward
chemoattract
inflamm
peptid
inhibit
fmlp
interact
cho
cell
viral
pathogenesi
isopropylureidoflflf
inhibit
chemotaxi
inflamm
spinorphin
inhibit
calcium
mobil
fmlp
induc
neutrophil
chemotaxi
inflamm
inhibit
chemotaxi
calcium
flux
superoxid
gener
erk
phosphoryl
neurodegen
diseas
ai
mi
myocardi
infarct
mir
myocardi
ischemia
reperfus
ai
acut
ischem
stroke
interferon
gamma
mapk
mitogenactiv
protein
kinas
erk
extracellular
signalregul
kinas
akt
serinethreonineprotein
kinas
pmn
polymorphonuclear
leukocyt
cho
cell
chines
hamster
ovari
atl
aspirin
trigger
lipoxin
asa
aspirin
igg
immunoglobulin
g
fmlp
formylmetleuph
fmlp
g
protein
flipr
inhibitori
protein
summari
cvd
lead
caus
morbid
mortal
worldwid
mi
primari
caus
death
major
cvd
relat
complic
due
iri
henc
becom
imper
develop
prevent
well
therapeut
strategi
mitig
lifethreaten
complic
review
focu
peptid
mimet
possibl
therapeut
strategi
treatment
iri
base
abil
allevi
thrombosi
inflamm
promot
resolut
figur
inde
drug
develop
program
focus
endogen
antiinflammatori
proresolv
agent
pharmacolog
strategi
offer
great
therapeut
potenti
devoid
metabol
side
effect
mimic
way
inflamm
natur
subsid
bodi
howev
develop
novel
therapeut
also
mind
ascertain
drug
antiinflammatori
also
resolutiontox
ie
derang
impair
time
andor
complet
resolut
could
ultim
outweigh
overal
therapeut
efficaci
treat
iri
inflammatori
disord
figur
schemat
represent
protect
effect
iri
bind
member
fpr
famili
peptid
mimet
decreas
roll
adhes
emigr
leukocyt
monocyt
neutrophil
addit
platelet
aggreg
diminish
proinflammatori
mediat
eg
myeloperoxidas
mpo
reactiv
oxygen
speci
ro
cytokin
moder
b
promot
balanc
proinflammatori
antiinflammatori
cytokin
therebi
foster
homeostasi
host
c
disrupt
barrier
function
due
loss
junction
molecul
apoptosisnecrosi
endothelialepitheli
cell
one
main
characterist
iri
posit
effect
maintain
barrier
function
reduc
edema
inhibit
loss
junction
molecul
particular
occludin
vecadherin
actin
cytoskeleton
thu
regul
inflammatori
respons
elicit
iri
lead
resolut
inflamm
decreas
tissu
injuri
differ
vascular
bed
